Publication | Closed Access

Salinomycin attenuates liver cancer stem cell motility by enhancing cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signalling pathway

Tumor BiologySignaling PathwayCell RegulationTumor MicroenvironmentMedicineF-actin FormationCell ProliferationCell StiffnessCellular BiochemistryRadiation OncologyCancer BiologyCell BiologyCell SignalingCellular PhysiologyCancer ResearchCancer GrowthCancer StemHealth Sciences